NCT01994460View on ClinicalTrials.gov

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

PHASE2UnknownINTERVENTIONAL
Enrollment

429

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2016

Conditions
Pulmonary Tuberculosis Without Resistance to Rifampicin
Interventions
DRUG

Linezolid

DRUG

Ethambutol

Trial Locations (3)

463-707

RECRUITING

Seoul National University Bundang Hospital, Seongnam

100-799

RECRUITING

National Medical Center, Seoul

156-707

RECRUITING

SMG-SNU Boramae Medical Center, Seoul

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Ministry of Health & Welfare, Korea

OTHER_GOV

collaborator

SMG-SNU Boramae Medical Center

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Pfizer

INDUSTRY

lead

Seoul National University Hospital

OTHER